| 产品描述: | ELOVL1-IN-2, a compound known as an inhibitor of the elongation of very long chain fatty acid 1 (ELOVL1) enzyme, exhibits a weak inhibitory effect on ELOVL1 (with an IC50 of 21 μM) and demonstrates moderate potency in a primary cellular assay conducted on HEK293 C26 cells (with an IC50 of 6.7 μM) |
| 靶点: |
ELOVL1:21 μM, HEK293 C26:6.7 μM |
| 参考文献: |
1. Boyd MJ, Collier PN, Clark MP, et al. Discovery of Novel, Orally Bioavailable Pyrimidine Ether-Based Inhibitors of ELOVL1. J Med Chem. 2021;64(24):17777-17794. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.398 ml |
16.988 ml |
33.977 ml |
| 5 mM |
0.68 ml |
3.398 ml |
6.795 ml |
| 10 mM |
0.34 ml |
1.699 ml |
3.398 ml |
| 50 mM |
0.068 ml |
0.34 ml |
0.68 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |